Remove Chemotherapy Remove FDA Remove Mayo Clinic
article thumbnail

ASH roundup: late breakers take the stage

pharmaphorum

At ASH, the E1910 clinical trial generated results could unlock a new patient population for Blincyto, after it was shown to improve overall survival in patients with no measurable residual disease (MRD) after induction chemotherapy for B-ALL. At the moment, Blincyto is approved to treat patients with MRD after induction treatment.

article thumbnail

CoQ10 side effects and how to avoid them

The Checkup by Singlecare

Safety measures while using CoQ10 What are the FDA warnings about CoQ10? The Food and Drug Administration (FDA) has not issued any warnings about CoQ10. It is available over the counter, so the FDA has determined that it’s safe to use without medical supervision. Who should never take CoQ10? Who should use caution with CoQ10?

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What causes sharp pain on the right side of the body?

The Checkup by Singlecare

According to the CDC , treatment includes surgery, chemotherapy, radiation therapy, targeted therapy, or a combination of these treatments. To help decrease the risk of shingles, Shingrix vaccine is FDA-approved for adults 50 and older. Antiviral medications such as Acyclovir ( zovirax ) and famciclovir are often prescribed.

article thumbnail

Ondansetron interactions to avoid

The Checkup by Singlecare

Sources Monoamine oxidase inhibitors (MAOIs) , Mayo Clinic (2019). Cleveland Clinic (2023). The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond? Mayo Clinic (2022). Journal of hospital medicine (2010). Phenylketonuria.